Frontlight ResearchEarly access
Taking people in EgyptPhase 3
Tests mebendazole with chemotherapy in adults with colorectal cancer
Tests mebendazole added to chemotherapy in adults with colorectal cancer.
Key facts
- Who runs it
- Sherief Abd-Elsalam
- Where
- Cairo, EgyptSee the site
- Trial code
- Registry title
- Mebendazole as Adjuvant Treatment for Colon Cancer
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 40 people, planned
- Started
- 1 Apr 2019
- Expected to end
- Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Folfox with avastin
- Mebendazole
- Record updated
- 24 April 2019
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with stage 4 colorectal cancer. It tests mebendazole as an add-on to the usual treatment.
- Age
- 18 years and older
- Sex
- Women and men can join
- Disease stage
- Colorectal cancer, stage 4
Main reasons for not taking part
- Agranulocytosis
- Pregnancy
- Allergy to mebendazole
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Colorectal cancer stage 4
Who cannot take part
- Allergy to mebendazole
- Agranulocytosis
- Pregnancy
Where in Egypt
- Sherief Abd-ElsalamCairo, EgyptContact: Sherief Abd-elsalam, lecturerTaking people
About the trial
What the trial wants to find out
mebendazole treating colon cancer
The 2 groups in the trial
- Folfox with avastinExisting treatment, for comparison
Folfox with avastin only
- MebendazoleTreatment being tested
Folfox with avastin with mebendazole
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer
- Plain-language title
- Tests mebendazole with chemotherapy in adults with colorectal cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 24 April 2019